Income Taxes (Details Textual) - USD ($)	12 Months Ended
Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2015
Deferred Tax Assets, Operating Loss Carryforwards	$ 15,435,000	$ 9,202,000
Operating Loss Carryforwards	$ 32,800,000	17,300,000
Net Operating Losses Expiration Description	expire in 2031 through 2036.
Ampio Pharmaceuticals [Member]
Deferred Tax Assets, Operating Loss Carryforwards	$ 4,500,000
Operating Loss Carryforwards		$ 42,300,000	$ 24,800,000

Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 25
-Paragraph 20
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=96869850&loc=d3e28680-109314

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32621-109319

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32632-109319

Name:	us-gaap_DeferredTaxAssetsOperatingLossCarryforwards
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant